Using the 2 Stage Free Cash Flow to Equity, Monopar Therapeutics fair value estimate is US$168 Monopar Therapeutics is estimated to be 46% undervalued based on current share price of US$91.56 The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback